SID 2026Abstract 0478Laboratory research
Anti-IL-15 in a clinical trial in vitiligo
durable reduction in circulating terminally differentiated cytotoxic CD8 T cells associates with increased skin repigmentation
Cooney L, Smilek DE, Lytle M, Boyle K, Sherman MA, Gao W, Li L, Bromstead C, Tosta P, Rosmarin D, Sobell J, Ganesan A, Hamzavi I, Han G, Huang V, Rashighi M, King BA
SID Annual Meeting 2026Chicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Pigmentary disorders
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.509 · Not in PubMed: details from Crossref